ETFs

The top ETF news, analyses and in-depth articles on stock, bond, commodity, sector and other ETFs.

VIP drug-approval pass costs $125 million and climbing

January 07, 2015

VIP drug-approval pass costs $125 million and climbing
VIP drug-approval pass costs $125 million and climbing

January 07, 2015

VIP drug-approval pass costs $125 million and climbing
Vanguard to Offer Its First Muni Bond Index Fund, ETF

January 07, 2015

Vanguard to Offer Its First Muni Bond Index Fund, ETF
Gilead makes exclusive deal with CVS for hepatitis C drugs

January 06, 2015

Gilead makes exclusive deal with CVS for hepatitis C drugs
Gilead makes exclusive deal with CVS for hepatitis C drugs

January 06, 2015

Gilead makes exclusive deal with CVS for hepatitis C drugs
Oil Price Decline Provides Support to Emerging Market Infrastructure Development

January 05, 2015

Oil Price Decline Provides Support to Emerging Market Infrastructure Development
Top 18 Fund Managers of 2014: Morningstar

January 05, 2015

Top 18 Fund Managers of 2014: Morningstar